Open AccessComparative Efficacy of 9 Major Drugs for Postendoscopic Retrograde Cholangiopancreatography Pancreatitis: A Network Meta-Analysis
Author(s) -
Yunxiao Lyu,
Bin Wang,
Yunxiao Cheng,
Yueming Xu,
Weibing Du
Publication year - 2019
Publication title -
surgical laparoscopy endoscopy and percutaneous techniques/surgical laparoscopy, endoscopy and percutaneous techniques
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.528
H-Index - 62
eISSN - 1534-4908
pISSN - 1530-4515
DOI - 10.1097/sle.0000000000000707
Subject(s) - medicine , randomized controlled trial , octreotide , diclofenac , meta analysis , cochrane library , placebo , odds ratio , pancreatitis , gastroenterology , pharmacology , somatostatin , alternative medicine , pathology
Postendoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is one of the most common complications after ERCP. The optimal drugs for reducing the risk of PEP are still unclear. This study aimed to compare the efficacy of 9 major drugs used worldwide for the prevention of PEP through a network meta-analysis.